Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 28, 2017; 23(28): 5146-5157
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5146
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5146
Figure 6 Effects of monocyte therapy on the cytokine profile of tumor necrosis factor-alpha (A), interleukin-1β (B), interleukin-6 (C) and interleukin-13 (D), as measured by enzyme-linked immunosorbent assay.
Data are represented graphically as the mean ± SEM of 5 mice/group. aP < 0.05; bP < 0.01. BMMCs: Bone marrow mononuclear cells; IL: Interleukin; TNF-α: Tumor necrosis factor-alpha.
- Citation: de Souza VCA, Pereira TA, Teixeira VW, Carvalho H, de Castro MCAB, D’assunção CG, de Barros AF, Carvalho CL, de Lorena VMB, Costa VMA, Teixeira ÁAC, Figueiredo RCBQ, de Oliveira SA. Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress. World J Gastroenterol 2017; 23(28): 5146-5157
- URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5146.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5146